Treatment of IBD patients diagnosed with systemic onset juvenile idiopathic arthritis with IL-1β antagonists showed well-controlled systemic juvenile idiopathic arthritis (sJIA) symptoms at time of diagnosis of IBD [19]. The gene discussed is IL1B; the disease is systemic-onset juvenile idiopathic arthritis.